Paying users zone. Data is covered by 
.
Get 1 month access to Regeneron Pharmaceuticals Inc. for $13.99, or
get full access to entire website for at least 3 months from $49.99.
We accept:
Regeneron Pharmaceuticals Inc. (REGN)
Profitability Analysis
Difficulty: Beginner
Profitability ratios measure the company’s ability to generate profitable sales from its resources (assets).
Ratios (Summary)
Regeneron Pharmaceuticals Inc., profitability ratios
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).
| Ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Regeneron Pharmaceuticals Inc.’s gross profit margin deteriorated from 2016 to 2017 but then slightly improved from 2017 to 2018. |
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Regeneron Pharmaceuticals Inc.’s operating profit margin improved from 2016 to 2017 and from 2017 to 2018. |
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Regeneron Pharmaceuticals Inc.’s net profit margin improved from 2016 to 2017 and from 2017 to 2018. |
| Ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Regeneron Pharmaceuticals Inc.’s ROE deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level. |
| ROA | A profitability ratio calculated as net income divided by total assets. | Regeneron Pharmaceuticals Inc.’s ROA improved from 2016 to 2017 and from 2017 to 2018. |
Gross Profit Margin
Regeneron Pharmaceuticals Inc., gross profit margin calculation, comparison to benchmarks
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).
2018 Calculations
1 Gross profit margin = 100 × Gross profit ÷ Revenues
= 100 × ÷ =
| Ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Regeneron Pharmaceuticals Inc.’s gross profit margin deteriorated from 2016 to 2017 but then slightly improved from 2017 to 2018. |
Operating Profit Margin
Regeneron Pharmaceuticals Inc., operating profit margin calculation, comparison to benchmarks
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).
2018 Calculations
1 Operating profit margin = 100 × Income from operations ÷ Revenues
= 100 × ÷ =
| Ratio | Description | The company |
|---|---|---|
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Regeneron Pharmaceuticals Inc.’s operating profit margin improved from 2016 to 2017 and from 2017 to 2018. |
Net Profit Margin
Regeneron Pharmaceuticals Inc., net profit margin calculation, comparison to benchmarks
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).
2018 Calculations
1 Net profit margin = 100 × Net income ÷ Revenues
= 100 × ÷ =
| Ratio | Description | The company |
|---|---|---|
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Regeneron Pharmaceuticals Inc.’s net profit margin improved from 2016 to 2017 and from 2017 to 2018. |
Return on Equity (ROE)
Regeneron Pharmaceuticals Inc., ROE calculation, comparison to benchmarks
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).
2018 Calculations
1 ROE = 100 × Net income ÷ Stockholders’ equity
= 100 × ÷ =
| Ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Regeneron Pharmaceuticals Inc.’s ROE deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level. |
Return on Assets (ROA)
Regeneron Pharmaceuticals Inc., ROA calculation, comparison to benchmarks
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).
2018 Calculations
1 ROA = 100 × Net income ÷ Total assets
= 100 × ÷ =
| Ratio | Description | The company |
|---|---|---|
| ROA | A profitability ratio calculated as net income divided by total assets. | Regeneron Pharmaceuticals Inc.’s ROA improved from 2016 to 2017 and from 2017 to 2018. |